Página 1 dos resultados de 6337 itens digitais encontrados em 0.015 segundos

Medicines out of use and waste of medicines in a northern city of Portugal

Pinto, Isabel C.; Nascimento, Luís; Guilherme, M.; Magalhães, A.; Santos, E.; Vasques, R.
Fonte: Faculdade de Saúde Pública da Universidade de São Paulo Publicador: Faculdade de Saúde Pública da Universidade de São Paulo
Tipo: Conferência ou Objeto de Conferência
ENG
Relevância na Pesquisa
37.05%
Nowadays, it’s important to understand waste of medicines, destination of medicines out of use and knowledge that people have about it, since the lack of information can lead to serious consequences for public health and environment. This study aims to determine the proportion of waste of medicines in population of a northern city of Portugal and related factors and verify the knowledge and behavior about the destination of medicines out of use, like the Valormed. This cross-sectional and study used a questionnaire applied to 148 users of a Health Center of Bragança. Most were female (67.6%), aged over 45 (60.1%), with residence in rural environment (78.4%). The proportion of waste medicines was relatively low, 60.8% alleged always finish the medication packaging. There is thus a proportion waste of 39.2%. The reason for not finishing the medication packaging was because they feel better (53.4%) or inadequate size of packages (16.2%). However, 75.0% said always check the expiration date. 31.1% of individuals lay medicines out of use to trash, 29.1% deliver in pharmacies and 27.7% keep at home. The majority (72.3%) did not know the existence of Valormed in pharmacies, as correct destination for medicines out of use. The proportion of waste of medicines was about 39%...

Um enfoque sanitário sobre a demanda judicial de medicamentos; A sanitary focus on medicines lawsuit

FIGUEIREDO, Tatiana Aragão; PEPE, Vera Lúcia Edais; OSORIO-DE-CASTRO, Claudia Garcia Serpa
Fonte: IMS-UERJ Publicador: IMS-UERJ
Tipo: Artigo de Revista Científica
POR
Relevância na Pesquisa
37.04%
No Brasil, apesar dos avanços da assistência farmacêutica, permanecem falhas na garantia do acesso dos cidadãos aos medicamentos pelo Estado. Nos últimos anos, vem crescendo a reivindicação de medicamentos por parte do cidadão via sistema judiciário. Os objetos dessas solicitações são tanto os medicamentos em falta na rede pública como aqueles ainda não incorporados pelo Sistema Único de Saúde. Este fenômeno pode ser analisado sob diferentes perspectivas, inclusive a sanitária, entendida aqui como os desfechos sobre a saúde dos indivíduos que demandam estes medicamentos. O presente texto busca discutir as principais características das demandas judiciais frente aos seguintes aspectos: o uso racional de medicamentos, o uso de evidências científicas para a indicação terapêutica proposta e o quanto as demandas se justificam diante do conceito de acesso adotado pelo campo da assistência farmacêutica. Ponderações podem ser feitas no sentido de minimizar os riscos à saúde dos demandantes de medicamentos por via judicial, sobretudo quando o objeto da ação são medicamentos não pertencentes às listas de fornecimento público, ou com uso off label, ou desprovidos de registro no país. Considera-se que o Judiciário...

Implantação, evolução, aspectos técnicos e perspectivas da regulamentação técnica de biodisponibilidade relativa e bioquivalência de medicamentos genéricos e similares no Brasil; The implementation, evolution, technical aspects and perspectives regarding technical regulation of relative bioavailability and bioequivalence of generic and similar medicines in brazil

Bueno, Marcia Martini
Fonte: Biblioteca Digitais de Teses e Dissertações da USP Publicador: Biblioteca Digitais de Teses e Dissertações da USP
Tipo: Dissertação de Mestrado Formato: application/pdf
Publicado em 14/03/2005 PT
Relevância na Pesquisa
37.08%
A Política de Saúde no Brasil, que inclui a Política Nacional de Medicamentos, a criação da Agência Nacional de Vigilância Sanitária (ANVISA), a promulgação da Lei de Medicamentos Genéricos, bem como a publicação das Resoluções que estabelecem os critérios técnicos para seu registro, revolucionou o mercado farmacêutico brasileiro na última década, introduzindo vários conceitos como Equivalência Farmacêutica e Terapêutica, Biodisponibilidade e Bioequivalência. Tais conceitos constituem as bases científicas para a implantação dos medicamentos genéricos, aliados à certificação de Boas Práticas de Fabricação e Controle de Qualidade (BPFs). Após cinco anos, os medicamentos genéricos representam cerca de 10% do mercado farmacêutico brasileiro em unidades com redução mínima de 35% no preço do genérico em relação ao medicamento de referência, em função de que o fabricante não necessita investir em estudos clínicos para comprovação da eficácia e segurança, garantidas pela comprovação da equivalência terapêutica com o medicamento de referência. O mercado brasileiro de genéricos é muito atrativo, pois 86% dos fármacos registrados no país não são patenteados e mais de 50% da população brasileira não tem acesso a medicamentos por problemas econômicos. Por outro lado...

Perfil da utilização de medicamentos não licenciados e sem indicação para crianças em UTI neonatal de Hospital Universitário de média complexidade ; The use of unlicensed and off label medicines for children admitted to the neonatal intensive care unit of a median complexity university Hospital in São Paulo

Brassica, Sandra Cristina
Fonte: Biblioteca Digitais de Teses e Dissertações da USP Publicador: Biblioteca Digitais de Teses e Dissertações da USP
Tipo: Dissertação de Mestrado Formato: application/pdf
Publicado em 03/11/2009 PT
Relevância na Pesquisa
37%
Introdução. Medicamentos não licenciados e sem indicação são utilizados com grande frequência em pediatria por razões éticas e econômicas. A utilização destes medicamentos não constitui um preceito ilegal, mas pode oferecer risco aos pacientes, sendo responsabilidade do médico e do farmacêutico qualquer evento adverso ocasionado. Alguns estudos nesta população sugerem aumento do risco de reações adversas relacionadas ao uso de medicamentos fora das indicações licenciadas. Objetivo. Analisar a exposição a medicamentos não licenciados e sem indicação em neonatos admitidos em Unidade de Terapia Intensiva (UTINEO) em hospital universitário de média complexidade de São Paulo, Brasil. Método. Estudo descritivo transversal dos medicamentos prescritos nas primeiras 24 horas de internação para 79 pacientes admitidos na Unidade de Terapia Intensiva Neonatal, do Hospital Universitário da Universidade de São Paulo (HU-USP), campus de São Paulo, no período de 12/03/08 a 03/11/08. Os medicamentos foram classificados em não licenciados e sem indicação para utilização por população neonatal de acordo com critérios de registro brasileiros e americanos. Resultados: foram prescritos 346 medicamentos. De acordo com os critérios brasileiros de licenciamento 58% não estavam licenciados...

Utilização de plantas medicinais e medicamentos no autocuidado no município de Teutônia, RS; Use of medicinal plants and medicines in selfcare in Teutônia city, RS

Schwambach, Karin Hepp
Fonte: Universidade Federal do Rio Grande do Sul Publicador: Universidade Federal do Rio Grande do Sul
Tipo: Dissertação Formato: application/pdf
POR
Relevância na Pesquisa
36.98%
Objetivos: descrever a utilização de plantas medicinais e fitoterápicos concomitantemente com outros medicamentos na população do município de Teutônia, RS. Métodos: a pesquisa seguiu um modelo transversal descritivo e o instrumento de coleta de dados foi um questionário semi-estruturado. As entrevistas ocorreram no período de dezembro de 2005 a maio de 2006. As plantas coletadas foram identificadas botanicamente pelo Herbário ICN/UFRGS, do Departamento de Botânica da UFRGS. Resultados e Conclusões: Dos 196 entrevistados 87,2% eram do sexo feminino, com idade média de 44,4+13,86 anos. O uso de plantas medicinais foi relatado por 92,9% dos entrevistados, com média de 4,8+3,7 plantas por pessoa. Para a maioria dos respondentes (74,8%) a informação sobre o uso das plantas medicinais está baseada no conhecimento tradicional, sendo usadas principalmente para tratar sintomas de condições relacionadas ao trato gastrintestinal, ao sistema respiratório ou simplesmente como bebida. 58,6% das plantas medicinais referidas são cultivadas nas moradias dos entrevistados. Quanto à utilização de medicamentos, 37,8% dos entrevistados relataram que utilizam medicamentos sempre, 31,1% quando não se sentem bem e 8,7% somente quando consultam o médico. Das pessoas entrevistadas...

Perfil de uso, valor intrínseco, custos diretos de medicamentos e qualidade de vida de idosos participantes de grupos de convivência em Porto Alegre/RS; Use profile, intrinsic value, direct cost of medicines and quality of life of elderly participants in acquaintanceship groups in Porto Alegre, RS, Brazil

Colet, Christiane de Fátima
Fonte: Universidade Federal do Rio Grande do Sul Publicador: Universidade Federal do Rio Grande do Sul
Tipo: Dissertação Formato: application/pdf
POR
Relevância na Pesquisa
36.95%
O envelhecimento populacional está correlacionado com o aumento dos custos e dos cuidados em saúde, e pela piora na qualidade de vida. O objetivo deste estudo é conhecer o perfil de consumo de medicamentos e o índice de qualidade de vida de grupos de pacientes idosos usuários do SUS e de planos de saúde privado e descrever o custo mensal do tratamento. A pesquisa seguiu um modelo de estudo transversal, e utilizou como instrumento de coleta de dados dois questionários estruturados, com amostragem foi do tipo intencional. O projeto foi aprovado pelo CEP/UFRGS. A coleta de dados foi realizada no período de março a julho de 2007, com 225 idosos, sendo: 61 na classe A, 80 na classe C e de 84 na classe E. A maioria era do sexo feminino, com idade média de 70 anos. O número médio de medicamentos citados foi: na classe A= 5,34; C= 4,07; E= 4,28. O custo de referência dos medicamentos variou entre as classes sociais estudadas, sendo: na classe A, de R$ 226,55 (DP±161,92), na classe C de R$ 72,32 (DP±82,86). O custo social dos medicamentos foi: na classe A de 210,03(DP±152,52); na classe C de 86,10 (DP±80,09) e para classe E de 78,39 (DP±167,92). Estatisticamente observou-se que a classe A diferiu da demais em relação ao custo dos medicamentos. Na classificação dos medicamentos de acordo com o valor intrínseco foi observado que na classe A 39% dos medicamentos apresentaram valor elevado...

Use of Medicines Among a Brazilian Elderly Sample: A Cross-sectional Study

Pereira da Silva Marchini, Adriana Mathias; de Deco, Camila Porto; Vieira Silva, Michele Roberta; Lodi, Karina Bortolin; da Rocha, Rosilene Fernandes; Marchini, Leonardo
Fonte: Elsevier Taiwan Publicador: Elsevier Taiwan
Tipo: Artigo de Revista Científica Formato: 94-97
ENG
Relevância na Pesquisa
36.92%
Background: The use of multiple medicines is very frequent among the elderly, allowing them to perceive more often adverse side effects from drugs and present undesirable drug interactions.Methods: This article presents a cross-sectional survey about the use of medicines among 300 elderly Brazilians, equally divided into institutionalized and community-dwelling groups.Results: The average daily intake of medicines is 3.2 among institutionalized elderly, a higher (p < 0.001) number when compared with community-dwelling elderly, who takes an average of 1.8 medicines daily. The most commonly used medications are antihypertensives (58.0%), diuretics (23.0%), nonsteroidal anti-inflammatory drugs (22.7%), supplements (21.7%), antidiabetics (16.3%), and antiulcerants (14.0%). Antiulcerants, diuretics, supplements, and central nervous system drugs are more frequently used by institutionalized than by community-dwelling elderly.Conclusion: In this Brazilian elderly sample, the most widely used medicines were antihypertensives, diuretics, and nonsteroidal anti-inflammatory drugs, and institutionalized used more medications than community-dwelling elderly. Copyright (C) 2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.

Diagnosis of Public Programs focused on Herbal Medicines in Brazil

Camargo, Ely Eduardo Saranz; Bandeira, Mary Anne Medeiros; Oliveira, Anselmo Gomes de
Fonte: Natural Products Inc Publicador: Natural Products Inc
Tipo: Artigo de Revista Científica Formato: 1001-1002
ENG
Relevância na Pesquisa
36.95%
The present study is aimed to diagnose the current public programs focused on herbal medicines in Brazil by means of in loco visits to 10 programs selected by means of questionnaires sent to 124 municipalities that count on herbal medicine services. The main purpose of the implementation of program programs is related to the development of medicinal herbs. 70% of them are intended for the production of herbal medicines and 50% are aimed to ensure the access of the population to medicinal plants and or herbal medicines. The initiative of the implementation of these programs was related to the managers (60%). The difficulties in this implementation were due to the lack of funding (100%) of the programs. In 60% of the programs, the physicians did not adhere to herbal medicine services due to the lack of knowledge of the subject. Training courses were proposed (80%) to increase the adhesion of prescribers to the system. Some municipalities use information obtained from patients to assess the therapeutic efficiency of medicinal plants and herbal medicines. of the programs underway, cultivation of medicinal plants was observed in 90% and 78% of them adopt quality control. In most programs, this control is not performed in accordance with the legal requirements. The programs focused on medicinal plants and herbal medicines implemented in Brazil face sonic chronic problems of infrastructure...

Safety assessment of essential medicines for elderly people: a bibliographic survey

Varallo,Fabiana Rossi; Oliveira,Fernanda Mariana de; Mastroianni,Patrícia de Carvalho
Fonte: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas Publicador: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
Tipo: Artigo de Revista Científica Formato: text/html
Publicado em 01/06/2014 EN
Relevância na Pesquisa
36.98%
Certain medicines are considered potentially inappropriate (PIM) for elderly people as they increase the risk of adverse drug events (ADE) and because safer alternative therapies are available on the market. In this context, in order to identify the instruments that assess the quality of medical prescriptions for elderly and to determine which drugs are considered PIM, a bibliographic survey was conducted in PUBMED, LILACS and PAHO databases, in February and March/2010. The search strategy included the use of health descriptors and a manual search in the references cited by selected papers. During the period of data collection, 15 instruments were identified. In 2012, with the publication of the update of Beers criteria, this instrument was included in the study. We identified 163 PIM of 25 therapeutic classes, of which 125 (76.7%) are marketed in Brazil. Of these, 31 (24.8%) are essential medicines (RENAME 2012), of which 13 have safer therapeutic equivalents and 19 (15.2%) are over-the-counter drugs. Data suggest the need for inclusion of safer alternatives for the elderly in the national list of essential medicines and the pharmaceutical care for early detection of ADE in this age group, in order to contribute to the safe use of medicines.

Impact of Universal Health Insurance Coverage in Thailand on Sales and Market Share of Medicines for Non-Communicable Diseases: an Interrupted Time Series Study

Garabedian, Laura Faden; Ross-Degnan, Dennis; Ratanawijitrasin, Sauwakon; Stephens, Peter; Wagner, Anita Katharina
Fonte: BMJ Publishing Group Publicador: BMJ Publishing Group
Tipo: Artigo de Revista Científica
EN_US
Relevância na Pesquisa
37.02%
Objective: In 2001, Thailand implemented the Universal Coverage Scheme (UCS), a public insurance system that aimed to achieve universal access to healthcare, including essential medicines, and to influence primary care centres and hospitals to use resources efficiently, via capitated payment for outpatient services and other payment policies for inpatient care. Our objective was to evaluate the impact of the UCS on utilisation of medicines in Thailand for three non-communicable diseases: cancer, cardiovascular disease and diabetes. Design: Interrupted time-series design, with a non-equivalent comparison group. Setting: Thailand, 1998–2006. Data: Quarterly purchases of medicines from hospital and retail pharmacies collected by IMS Health between 1998 and 2006. Intervention: UCS implementation, April–October 2001. Outcome measures Total pharmaceutical sales volume and percent market share by licensing status and National Essential Medicine List status. Results: The UCS was associated with long-term increases in sales of medicines for conditions that are typically treated in outpatient primary care settings, such as diabetes, high cholesterol and high blood pressure, but not for medicines for diseases that are typically treated in secondary or tertiary care settings...

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses

Leopold, Christine; Zhang, Fang; Mantel-Teeuwisse, Aukje K; Vogler, Sabine; Valkova, Silvia; Ross-Degnan, Dennis; Wagner, Anita K
Fonte: BioMed Central Publicador: BioMed Central
Tipo: Artigo de Revista Científica
EN_US
Relevância na Pesquisa
36.95%
Objectives: To analyze the impacts of pharmaceutical sector policies implemented to contain country spending during the economic recession – a reference price system in Finland and a mix of policies including changes in reimbursement rates, a generic promotion campaign and discounts granted to the public payer in Portugal – on utilization of, as a proxy for access to, antipsychotic medicines. Methodology We obtained monthly IMS Health sales data in standard units of antipsychotic medicines in Portugal and Finland for the period January 2007 to December 2011. We used an interrupted time series design to estimate changes in overall use and generic market shares by comparing pre-policy and post-policy levels and trends. Results: Both countries’ policy approaches were associated with slight, likely unintended, decreases in overall use of antipsychotic medicines and with increases in generic market shares of major antipsychotic products. In Finland, quetiapine and risperidone generic market shares increased substantially (estimates one year post-policy compared to before, quetiapine: 6.80% [3.92%, 9.68%]; risperidone: 11.13% [6.79%, 15.48%]. The policy interventions in Portugal resulted in a substantially increased generic market share for amisulpride (estimate one year post-policy compared to before: 22.95% [21.01%...

Quality use of medicines within universal health coverage: challenges and opportunities

Wagner, Anita K; Quick, Jonathan D; Ross-Degnan, Dennis
Fonte: BioMed Central Publicador: BioMed Central
Tipo: Artigo de Revista Científica
EN_US
Relevância na Pesquisa
37.05%
Background: Medicines are a major driver of quality, safety, equity, and cost of care in low and middle-income country health systems. Universal health coverage implementers must explicitly address appropriate use of medicines to realize the health benefits of medicines, avoid wasting scarce resources, and sustain the financial viability of universal health coverage schemes. Discussion Medicines are major contributors to the health and well-being of individuals and populations when used appropriately, and they waste resources and endanger health when used unnecessarily or incorrectly. Stakeholders need to balance inherently competing objectives in the pharmaceutical sector. Emerging and expanding UHC schemes provide potential levers to balance competing system objectives. To use these levers, sustainable universal coverage programs will require a) information systems that can track medicines utilization, expenditures, and quality of medicines use; b) routine monitoring of indicators of medicines availability, access, affordability, and use; c) policies and programs that facilitate appropriate medicines use by prescribers, dispensers, and patients; d) transparency in setting priorities for medicines coverage under resource constraints; and e) a system perspective to engage diverse actors. As they operationalize paths toward universal health coverage and include targeted medicines coverage policies and programs...

Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil

Emmerick, Isabel Cristina Martins; do Nascimento, José Miguel; Pereira, Marco Aurélio; Luiza, Vera Lucia; Ross-Degnan, Dennis
Fonte: BioMed Central Publicador: BioMed Central
Tipo: Artigo de Revista Científica
EN_US
Relevância na Pesquisa
36.95%
Objectives: The Brazilian constitution guarantees the right to health, including access to medicines. In May 2004, Brazil’s government announced the “Farmácia Popular” Program (FPP) as a new mechanism to improve the Brazilian population’s access to medicines. Under FPP, a selected list of medicines is subsidized by the government and provided in public and private pharmacies. The aim of this study is to describe the historical stages of the FPP and to identify associated changes in the geographical accessibility of medicines through the FPP over time. Methods: It was performed documentary review and an ecological study assessing program coverage in terms of number of facilities and a FPP Pharmacy Facilities Density (PFD) index at national and regional levels from 2004 to 2013, using the FPP database. We used geographic information system mapping to depict a pharmaceutical facilities density (PFD) index at the municipality level on thematic maps. Results: A growth of the PFD index coincident with the phases of the FPP was noticed. In the public sector, the program started in 2004; by 2006, there was a sharp increase in the numbers of participating pharmacies, stabilizing in 2009. In the private sector, the program started in 2006; by 2009 the PFD ratio had increased substantially and it continued to grow through 2011. There was an increase in FPP coverage in most regions between 2006...

Ensaio de dissolução de fitoterápicos contendo Maytenus ilicifolia Mart ex Reiss (Celastraceae): validação de métodos para quantificação de catequina e epicatequina; Dissolution profiles of herbal medicines containing Maytenus ilicifolia Marth ex Reiss (Celastraceae)

LEAL, Ana Flavia Vasconcelos Borges
Fonte: Universidade Federal de Goiás; BR; UFG; Mestrado em Ciências Farmacêuticas; Ciências da Saúde - Farmácia Publicador: Universidade Federal de Goiás; BR; UFG; Mestrado em Ciências Farmacêuticas; Ciências da Saúde - Farmácia
Tipo: Dissertação Formato: application/pdf
POR
Relevância na Pesquisa
36.98%
Maytenus ilicifolia Mart ex Reiss (Celastraceae) popularly known in Brazil as espinheirasanta is used against gastric disorders and ulcers. Quality of herbal medicines is essential to ensure the safety and efficacy of the drug. The dissolution test is an essential tool to assess the quality of herbal medicines in the solid dosage form for oral use. This work aimed to evaluate the dissolution behavior of eleven herbal medicines containing Maytenus ilicifolia, produced with powder or dry extract, purchased in local shops (Goiânia-GO, Brazil). Assay of catechin and epicatechin by high-pressure liquid chromatography (HPLC) and dissolution methods were validated and obtained results allowed the quantification of these markers with precision, accuracy and selectivity. The dissolution profiles have been determined adopting the following conditions: paddle apparatus at 75 rpm and HCl 0.1 M (900 mL at 37°C ± 0.5°C) as dissolution medium. Through the dissolution profiles it has been determined the mathematical model of release (first order), the percentage of catechin and epicatechin dissolved at 45 minutes and the efficiency of dissolution. Capsule containing powder showed rapid release of the markers in the medium (Q>85% in 12 minutes). Tests conducted to verify the quality of herbal medicines were average weight...

Perceptions and attitudes of community pharmacists towards generic medicines.

Dunne, Suzanne S.; Shannon, Bill; Cullen, Walter; Dunne, Colum
Fonte: Academy of Managed Care Pharmacy Publicador: Academy of Managed Care Pharmacy
Tipo: info:eu-repo/semantics/article; all_ul_research; ul_published_reviewed
ENG
Relevância na Pesquisa
36.95%
peer-reviewed; BACKGROUND: Following the enactment of legislation in June 2013, generic substitution and reference pricing of medicines has been introduced, for the first time, in Ireland. This novel study is the first assessment of the perceptions of community pharmacists in Ireland towards generic medicines completed in the period immediately prior to the introduction of generic substitution and reference pricing. OBJECTIVE: To determine the perceptions towards generic medicines among community pharmacists. METHODS: One-to-one semistructured interviews were performed with a convenience sample of 44 community pharmacists (from approximately 4,500 pharmacists in Ireland) recruited from Ireland’s Midwest, South, and Southwest regions. Interviews were transcribed and analysed using NVivo (version 9). RESULTS: 98% of pharmacists believed that generics were of a similar quality to the originator, and 96% stated that they were as effective as the originator. However, a small number demonstrated some reticence regarding generics: 9% believed that generics were not manufactured to the same quality as the originator; 7% stated they would prefer to take an originator medicine themselves; and 7% reported having experienced quality issues with generic medicines. 89% of pharmacists reported receiving patient complaints regarding use of generic medicine...

Generic medicines: a holistic assessment of stakeholder perceptions and online information provision

Dunne, Suzanne S.
Fonte: University of Limerick Publicador: University of Limerick
Tipo: info:eu-repo/semantics/doctoralThesis; all_ul_research; ul_published_reviewed; ul_theses_dissertations
ENG
Relevância na Pesquisa
37.09%
peer-reviewed; Background: Generic medicines result from expired intellectual property protection and the ability of pharmaceutical producers, other than originator companies, to manufacture analogous medicines containing identical active ingredients and to distribute them in relevant markets. Cost reductions associated with procurement of generics by national agencies, and subsequent savings for patients buying generic medicines from pharmacies, result in policies regarding generic medicines and reference pricing being promoted by governments internationally. In Ireland, however, generic medicines usage has been poor historically and attitudes of stakeholders, other than the Irish Government, have been relatively negative. In June 2013 the Health (Pricing and Supply of Medical Goods) Act was signed into law, meaning that Irish patients are now more likely than ever before to receive a generic medicine. Objectives From 2013, general practitioners (GPs) and pharmacists alike are likely to encounter greater patient awareness, and discussion, of generic medicines, their potential benefits and disadvantages. This thesis focused initially on providing a comprehensive description of generic medicines and their development and...

Assuring the Quality of Essential Medicines Procured with Donor Funds

Moore, Thomas; Lee, David; Konduri, Niranjan; Kasonde, Lombe
Fonte: World Bank, Washington, DC Publicador: World Bank, Washington, DC
EN_US
Relevância na Pesquisa
37.07%
The donor community spends millions of dollars annually on procuring essential medicines as part of development assistance for health. Defining and enforcing quality standards for these medicines continues to prove challenging as this involves complex regulatory processes. While developed countries with stringent regulatory authorities in place have the capacity to comply with strict regulatory requirements, the essential medicines procured for developing countries are either not available in developed country markets, or are not the most competitively priced medicines internationally. Donors have therefore been forced to independently develop systems to purchase at lowest feasible cost, essential medicines for the developing world without compromising quality. Through a desk review and consultation with key stakeholders, this paper compiles data on various approaches used by international agencies and donor bodies to improve the quality of essential medicines they procure, beyond the World Health Organization (WHO) prequalification of medicines program and the global fund expert review panel...

Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans

Roughead, E.; Kalisch Ellett, L.; Ramsay, E.; Pratt, N.; Barratt, J.; LeBlanc, V.; Ryan, P.; Peck, R.; Killer, G.; Gilbert, A.
Fonte: BioMed Central Ltd. Publicador: BioMed Central Ltd.
Tipo: Artigo de Revista Científica
Publicado em //2013 EN
Relevância na Pesquisa
36.98%
BACKGROUND The Australian Government Department of Veterans’ Affairs (DVA) funds an ongoing health promotion based program to improve use of medicines and related health services, which implements interventions that include audit and feedback in the form of patient-specific feedback generated from administrative claims records. We aimed to determine changes in medicine use as a result of the program. METHODS The program provides targeted patient-specific feedback to medical practitioners. The feedback is supported with educational material developed by a clinical panel, subject to peer review and overseen by a national editorial committee. Veterans who meet target criteria also receive educational brochures. The program is supported by a national call centre and ongoing national consultation. Segmented regression analyses (interrupted time series) were undertaken to assess changes in medication use in targeted veterans pre and post each intervention. RESULTS 12 interventions were included; three to increase medicine use, seven which aimed to reduce use, and two which had combination of messages to change use. All programs that aimed to increase medicine use were effective, with relative effect sizes at the time of the intervention ranging from 1% to 8%. Mixed results were seen with programs aiming to reduce inappropriate medicine use. Highly specific programs were effective...

An evaluation of generic medicines availability in pharmacies and drugstores in Maringá (PR) and comparison of their prices in relation with the similars and the references; Avaliação da disponibilidade de medicamentos genéricos em farmácias e drogarias de Maringá (PR) e comparação de seus preços com os de referência e similares

Monteiro, Wuelton Marcelo; Melo, Gisely Cardoso de; Massunari, Gustavo Kiyoshi; Hübner, Dirce Vendrametto; Tasca, Raquel Soares
Fonte: Universidade de São Paulo. Faculdade de Ciências Farmacêuticas Publicador: Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
Tipo: info:eu-repo/semantics/article; info:eu-repo/semantics/publishedVersion; Artigo Avaliado pelos Pares Formato: application/pdf
Publicado em 01/09/2005 POR
Relevância na Pesquisa
37%
The discussion about the implementation of generics has being carried trough since 1976 in Brazil. However, just in 1991 a project which proposes the implantation of generic medicines has been elaborated. The Law 9787 (called Law of the Generic medicines) has been only published in Diário Oficial da União in February 11th, 1999. The objectives of this work had been to verify generic medicine availability in pharmacies and drugstores, as well as comparing their prices in relation with the similars and the references. The generic availability was verified in 22 pharmacies and drugstores in Maringá city, state of Paraná, from October, 30th to November, 20th ,2002. In a total of 222 active principles available in Brazil as generic, 71 (32%) had been found. Those generic medicines sold not under special control are in average 42% cheaper than the reference and 15% cheaper than the similar ones. Those generic medicines with red label, sold under special control, are in average 36% cheaper than the reference and 12% cheaper than the similar ones. The generic medicines with black label are 37% cheaper than the reference and 14% cheaper than the similars ones.; O debate sobre a implementação de genéricos vem sendo realizado no Brasil desde 1976. Entretanto...

Medicines in the work routine of community healthcare workers from Santa Cecília basic healthcare unit in Porto Alegre, RS, Brazil; O medicamento na rotina de trabalho dos agentes comunitários de saúde da unidade básica de saúde Santa Cecília, em Porto Alegre, RS, Brasil

Nunes, Carla Cafarate; Amador, Tânia Alves; Heineck, Isabela
Fonte: Universidade de São Paulo. Faculdade de Saúde Pública Publicador: Universidade de São Paulo. Faculdade de Saúde Pública
Tipo: info:eu-repo/semantics/article; info:eu-repo/semantics/publishedVersion; ; ; Formato: application/pdf
Publicado em 01/03/2008 POR
Relevância na Pesquisa
37%
Desde o estabelecimento do Sistema Único de Saúde (SUS), busca-se enfatizar a atenção básica e a saúde familiar. Uma das estratégias que vem sendo utilizada é o Programa de Saúde da Família (PSF) constituído por equipes de profissionais que incluem os agentes comunitários de saúde. Entre os diversos problemas enfrentados pelas equipes de saúde da família está o uso irracional dos medicamentos. Este trabalho teve o objetivo de examinar o papel do medicamento na rotina dos agentes, estabelecer sua percepção em relação aos serviços da farmácia de uma unidade básica de saúde e identificar as necessidades de informação sobre medicamentos para elaboração de treinamento. Para tanto, foi realizada uma sessão utilizando-se a técnica grupo nominal, em que oito de onze agentes de saúde participaram respondendo a quatro perguntas. O medicamento foi considerado importante, com valorização das ações preventivas. A percepção em relação aos serviços da farmácia foi positiva. Segundo os agentes, as dúvidas sobre medicamentos, freqüentemente relatadas pela população, refletem falhas na consulta e na aquisição dos medicamentos. O agente de saúde é reconhecido pela população como o profissional que pode auxiliá-la no uso de medicamentos...